Anbio Biotechnology (NNNN) Historical Stock Prices
Anbio Biotechnology (NNNN) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NNNN
CIK: 1982708
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
GGF CPA LTD
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerXiaobin Chen
Audit LocationGuangzhou, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| F-3ASR | 2026-07-09 | — | AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU | 0001185185-26-002869 | View SEC Doc Filr Page |
| 3 | 2026-06-12 | 2026-03-18 | 3 Filing | 0001185185-26-002487 | View SEC Doc Filr Page |
| 3 | 2026-06-12 | 2026-03-18 | 3 Filing | 0001185185-26-002486 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | FORM 6-K | 0001185185-26-001897 | View SEC Doc Filr Page |
| 6-K | 2026-04-27 | 2026-04-27 | FORM 6-K | 0001185185-26-001504 | View SEC Doc Filr Page |
| 20-F/A | 2026-04-09 | 2025-12-31 | FORM 20-F/A1 | 0001185185-26-001313 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-03-18 | 3 Filing | 0001185185-26-001311 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-03-18 | 3 Filing | 0001185185-26-001310 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-03-18 | 3 Filing | 0001185185-26-001308 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-03-18 | 3 Filing | 0001185185-26-001307 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-03-18 | 3 Filing | 0001185185-26-001306 | View SEC Doc Filr Page |
| 20-F | 2026-04-07 | 2025-12-31 | FORM 20-F | 0001185185-26-001294 | View SEC Doc Filr Page |
| 6-K | 2026-02-17 | 2026-02-17 | FORM 6-K | 0001185185-26-000588 | View SEC Doc Filr Page |
| 6-K | 2026-01-26 | 2026-01-26 | FORM 6-K | 0001185185-26-000269 | View SEC Doc Filr Page |
| 6-K | 2025-12-30 | 2025-12-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-126654 | View SEC Doc Filr Page |
| 6-K | 2025-11-13 | 2025-11-12 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-109447 | View SEC Doc Filr Page |
| 20-F | 2025-04-28 | 2024-12-31 | ANNUAL REPORT | 0001213900-25-035802 | View SEC Doc Filr Page |
| 6-K | 2025-02-21 | 2025-02-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-016129 | View SEC Doc Filr Page |
| 424B4 | 2025-02-19 | — | PROSPECTUS | 0001213900-25-015001 | View SEC Doc Filr Page |
| EFFECT | 2025-02-18 | — | EFFECT Filing | 9999999995-25-000497 | View SEC Doc Filr Page |
| CERT | 2025-02-18 | — | CERT Filing | 0001354457-25-000115 | View SEC Doc Filr Page |
| CORRESP | 2025-02-14 | — | CORRESP Filing | 0001213900-25-014006 | View SEC Doc Filr Page |
| CORRESP | 2025-02-14 | — | CORRESP Filing | 0001213900-25-014005 | View SEC Doc Filr Page |
| 8-A12B | 2025-02-14 | — | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-013885 | View SEC Doc Filr Page |
| F-1/A | 2025-02-10 | — | REGISTRATION STATEMENT | 0001213900-25-011623 | View SEC Doc Filr Page |